Alzheimer Disease

Name
Alzheimer Disease
Accession Number
DBCAT003011
Description

Not Available

Drugs
DrugDrug Description
LatrepirdineLatrepirdine has been investigated for the treatment of Alzheimer's Disease and Huntington's Disease.
LecanemabAn amyloid beta-targeting antibody used to treat Alzheimer’s Disease in patients with mild cognitive impairment or mild dementia with a known amyloid beta pathology.
Drugs & Drug Targets
DrugTargetType
LecanemabAmyloid beta A4 proteintarget